Global Causes of Death to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

CUREXO, INC. (Symbol:060280) SWOT Analysis, Strategy, Revenues and Profits

CUREXO, INC. (Symbol:060280) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. CUREXO, INC. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: South Korea

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States, Spain, South Korea, Japan, China

South Korea Hernia Repair Market Outlook to 2020

South Korea Hernia Repair Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • July 2014
  • 36 pages

South Korea Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "South Korea Hernia Repair Market Outlook to 2020", provides key market data on the South Korea Hernia Repair market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Pathology | Countries: South Korea

Asia-Pacific Hernia Repair Market Outlook to 2020

Asia-Pacific Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • July 2014
  • 126 pages

Asia-Pacific Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Market Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repair market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US ...

Industries: Pathology | Countries: South Korea, Australia, Japan, India, China, Asia, World, Oceania

Green Cross Cell Corporation (031390) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Green Cross Cell Corporation (031390) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 20 pages

Summary Green Cross Cell (Green Cross), formerly Innocell Corporation, is a pharmaceutical company. The company develops immune cell treatment drugs and the storage of immune cells. It offers Immuncell-LC, an anti-cancer immune therapeutic drug to general hospitals and cancer centers for the treatment ...

Industries: Pathology | Countries: South Korea

Brain Tumor - Pipeline Review, H2 2014

Brain Tumor - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • July 2014
  • 90 pages

Brain Tumor - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Brain Tumor - Pipeline Review, H2 2014', provides an overview of the Brain Tumor's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Tumor, complete with comparative ...

Industries: Pathology | Countries: World, South Korea

Contact Dermatitis - Pipeline Review, H1 2014

Contact Dermatitis - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • May 2014
  • 38 pages

Contact Dermatitis - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Contact Dermatitis - Pipeline Review, H1 2014', provides an overview of the Contact Dermatitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contact Dermatitis, ...

Industries: Pathology | Countries: World, South Korea, New Zealand, Australia

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • May 2014
  • 38 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014', provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )'s therapeutic pipeline. ...

Industries: Pathology | Countries: World, South Korea

Sanofi (SAN) - Product Pipeline Analysis, 2014 Update

Sanofi (SAN) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • May 2014
  • 51 pages

Summary Sanofi is a diversified global healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company offers a broad range of prescription medicines, and consumer healthcare and generic products worldwide. It operates its business in three broad categories, ...

Industries: Pathology | Countries: United States, France, South Korea

Celltrion, Inc. (068270) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celltrion, Inc. (068270) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 23 pages

Summary Celltrion, Inc. (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. Under Biosimilars category, it focuses on the development of monoclonal antibodies (mAb) and its products include Remsima, for the treatment ...

Industries: Pathology | Countries: South Korea

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.